Bio-View Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Alan Schwebel
Chief executive officer
₪1.3m
Total compensation
| CEO salary percentage | 81.9% |
| CEO tenure | 15.2yrs |
| CEO ownership | 0.5% |
| Management average tenure | 12.9yrs |
| Board average tenure | no data |
Recent management updates
Shareholders Will Probably Not Have Any Issues With Bio-View Ltd's (TLV:BIOV) CEO Compensation
Dec 04
Recent updates
Shareholders Will Probably Not Have Any Issues With Bio-View Ltd's (TLV:BIOV) CEO Compensation
Dec 04Estimating The Intrinsic Value Of Bio-View Ltd (TLV:BIOV)
Feb 14Does BioView Ltd.'s (TLV:BIOV) Weak Fundamentals Mean That The Market Could Correct Its Share Price?
Jan 20What BioView Ltd.'s (TLV:BIOV) 35% Share Price Gain Is Not Telling You
Nov 29
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | ₪383k |
| Sep 30 2023 | n/a | n/a | ₪407k |
| Jun 30 2023 | n/a | n/a | ₪2m |
| Mar 31 2023 | n/a | n/a | ₪962k |
| Dec 31 2022 | ₪1m | ₪1m | ₪587k |
| Sep 30 2022 | n/a | n/a | ₪1m |
| Jun 30 2022 | n/a | n/a | ₪1m |
| Mar 31 2022 | n/a | n/a | ₪2m |
| Dec 31 2021 | n/a | n/a | ₪2m |
| Sep 30 2021 | n/a | n/a | ₪2m |
| Jun 30 2021 | n/a | n/a | ₪2m |
| Mar 31 2021 | n/a | n/a | ₪2m |
| Dec 31 2020 | n/a | n/a | ₪884k |
| Sep 30 2020 | n/a | n/a | ₪2m |
| Jun 30 2020 | n/a | n/a | ₪2m |
| Mar 31 2020 | n/a | n/a | ₪3m |
| Dec 31 2019 | n/a | n/a | ₪3m |
| Sep 30 2019 | n/a | n/a | ₪2m |
| Jun 30 2019 | n/a | n/a | -₪765k |
| Mar 31 2019 | n/a | n/a | -₪1m |
| Dec 31 2018 | ₪1m | ₪913k | -₪2m |
| Sep 30 2018 | n/a | n/a | -₪2m |
| Jun 30 2018 | n/a | n/a | -₪292k |
| Mar 31 2018 | n/a | n/a | -₪2m |
| Dec 31 2017 | ₪1m | ₪911k | -₪1m |
Compensation vs Market: Alan's total compensation ($USD340.16K) is about average for companies of similar size in the IL market ($USD436.57K).
Compensation vs Earnings: Alan's compensation has been consistent with company performance over the past year.
CEO
Alan Schwebel (69 yo)
15.2yrs
Tenure
₪1,260,000
Compensation
Dr. Alan Schwebel has been the Chief Executive Officer and President of Bio View Ltd. since March 19, 2009 and has served as its Director since September 7, 2009. Dr. Schwebel served as Vice President for...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 15.2yrs | ₪1.26m | 0.53% ₪ 188.3k | |
| Chief Financial Officer | 4.4yrs | no data | no data | |
| Chief Operating Officer | 12yrs | ₪644.00k | no data | |
| Vice President of Marketing | 13.8yrs | ₪872.00k | no data | |
| Deputy Chief Executive Officer | 15.2yrs | ₪829.00k | 0.35% ₪ 124.3k | |
| President & CEO of Bioview (USA) Inc. | no data | ₪822.00k | no data | |
| Chief Scientific Officer | 2.3yrs | no data | no data |
12.9yrs
Average Tenure
55yo
Average Age
Experienced Management: BIOV's management team is seasoned and experienced (12.9 years average tenure).